跳至主要内容
临床试验/NL-OMON46515
NL-OMON46515已完成不适用

Effects of wakame and spirulina consumption on intestinal cholesterol absorption in non-hypercholesterolemic men and women - Algae and cholesterol absorption

niversiteit Maastricht0 个研究点目标入组 37 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
37

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • * Apparently healthy men and women;
  • * Aged between 18 and 70 years;
  • * BMI between 18 and 30 kg/m2
  • * Non-smoking;
  • * No elevated serum triacylglycerol concentrations (< 4.5 mmol/L);
  • * Willing to comply to the study protocol during the study;
  • * Agreeing to be informed about medically relevant personal test-results.

排除标准

  • * Not willing to abstain from any algae and/or seaweed consumption or algae/seaweed containing products (including sushi, see appendix I) two weeks before the start and during the trial;
  • * Use of plant-sterol/stanol-enriched foods (e.g. Becel Proactive) or supplements in the four weeks prior to the screening and/or during the study;
  • * Use of cholesterol or lipid-lowering medications (e.g. statins, bile-acid sequestrates, cholesterol absorption inhibitors);
  • * Use of any kind of medication or a medically prescribed diet, which can interfere with the study (judged by the principal investigator);
  • * Use of oral antibiotics in 40 days or less prior to the start of the study;
  • * Use of food supplements that might interfere with study measurements (judged by the principal investigator) in four weeks or less prior to the start of the study;
  • * Indications of treatment according to the Standard for Cardiovascular Risk Management from the Dutch General Practitioners community (NHG 2012);
  • * Any medical condition that might interfere with study (measurements), judged by the principal investigator, including cardiovascular diseases or events (e.g. acute myocardial infarction or cerebro-vascular accident), diabetes, asthma, COPD, rheumatoid arthritis, and gastro-intestinal diseases (e.g. inflammatory bowel disease);
  • * Unstable body weight (weight gain or loss > 3 kg in the past 3 months);
  • * Females who are pregnant, breast feeding or who may wish to become pregnant during the study;
  • * Consumption of > 14 (males) or > 10 (females) alcoholic consumptions a week;
  • * Reported intense sporting activities > 10 hours a week;
  • * Abuse of drugs;
  • * Participation in any other biomedical trial four weeks prior to the screening visit;
  • * Having donated >150 ml blood within 1 month prior to the screening visit, planning to donate blood during the study or within one month after finishing the study;
  • * Impossible or difficult to puncture as evidenced during the screening visit.

研究者

相似试验

Effects of wakame and spirulina consumption on... | 临床试验